These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 33907881)

  • 21. Liposomal doxorubicin in breast cancer: new preparation. Much ado about nothing.
    Prescrire Int; 2003 Jun; 12(65):93-5. PubMed ID: 12825572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of low-protein diet on anthracycline pharmacokinetics and cardiotoxicity.
    El-Demerdash E; Ali AA; El-Taher DE; Hamada FM
    J Pharm Pharmacol; 2012 Mar; 64(3):344-52. PubMed ID: 22309266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different anthracycline derivates for reducing cardiotoxicity in cancer patients.
    van Dalen EC; Michiels EM; Caron HN; Kremer LC
    Cochrane Database Syst Rev; 2010 May; 2010(5):CD005006. PubMed ID: 20464735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different anthracycline derivates for reducing cardiotoxicity in cancer patients.
    van Dalen EC; Michiels EM; Caron HN; Kremer LC
    Cochrane Database Syst Rev; 2010 Mar; (3):CD005006. PubMed ID: 20238335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anthracycline extravasation: a comprehensive review of experimental and clinical treatments.
    Langer SW; Sehested M; Jensen PB
    Tumori; 2009; 95(3):273-82. PubMed ID: 19688963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-induced cardiotoxicity studied by longitudinal B-type natriuretic peptide assays and radionuclide ventriculography.
    Pichon MF; Cvitkovic F; Hacene K; Delaunay J; Lokiec F; Collignon MA; Pecking AP
    In Vivo; 2005; 19(3):567-76. PubMed ID: 15875778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer.
    Zaheed M; Wilcken N; Willson ML; O'Connell DL; Goodwin A
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012873. PubMed ID: 30776132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of elevated liver function parameters on the pharmacokinetics of doxorubicin and epirubicin--a population based pharmacokinetic study of CESAR-APOH. Central European Society for Anticancer Drug Research. Working Group for Pharmacology in Oncology and Hematology.
    Müller HJ; Grubert M; Hilger R; Richly H; Port R; Scheulen M; Mross K;
    Int J Clin Pharmacol Ther; 2002 Dec; 40(12):575-7. PubMed ID: 12503820
    [No Abstract]   [Full Text] [Related]  

  • 29. Epirubicin in combination with the taxanes.
    Trudeau M; Pagani O
    Semin Oncol; 2001 Aug; 28(4 Suppl 12):41-50. PubMed ID: 11552229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of cardiac events associated with liposomal doxorubicin, epirubicin and doxorubicin in breast cancer: a Bayesian network meta-analysis.
    Yamaguchi N; Fujii T; Aoi S; Kozuch PS; Hortobagyi GN; Blum RH
    Eur J Cancer; 2015 Nov; 51(16):2314-20. PubMed ID: 26343314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different anthracycline derivates for reducing cardiotoxicity in cancer patients.
    van Dalen EC; Michiels EM; Caron HN; Kremer LC
    Cochrane Database Syst Rev; 2006 Oct; (4):CD005006. PubMed ID: 17054231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CHEMOTHERAPY HAZARDS: ANTHRACYCLINE EXTRAVASATION INTO PLEURAL SPACE.
    Almendra A; Falcão P; Moreira S; Azevedo P
    Port J Card Thorac Vasc Surg; 2022 Apr; 29(1):61-63. PubMed ID: 35471214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Derivation of Anthracycline and Anthraquinone Equivalence Ratios to Doxorubicin for Late-Onset Cardiotoxicity.
    Feijen EAM; Leisenring WM; Stratton KL; Ness KK; van der Pal HJH; van Dalen EC; Armstrong GT; Aune GJ; Green DM; Hudson MM; Loonen J; Oeffinger KC; Robison LL; Yasui Y; Kremer LCM; Chow EJ
    JAMA Oncol; 2019 Jun; 5(6):864-871. PubMed ID: 30703192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dexrazoxane-a promising antidote in the treatment of accidental extravasation of anthracyclines.
    Jensen JN; Lock-Andersen J; Langer SW; Mejer J
    Scand J Plast Reconstr Surg Hand Surg; 2003; 37(3):174-5. PubMed ID: 12841619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epirubicin versus doxorubicin: which is the anthracycline of choice for the treatment of breast cancer?
    Kaklamani VG; Gradishar WJ
    Clin Breast Cancer; 2003 Apr; 4 Suppl 1():S26-33. PubMed ID: 12756076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doxorubicin liposomal pegylated: new preparation. Breast cancer: not just a question of short-term cardiac effects.
    Prescrire Int; 2004 Jun; 13(71):90-1. PubMed ID: 15233142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical dimethylsulfoxide may prevent tissue damage from anthracycline extravasation.
    Lawrence HJ; Walsh D; Zapotowski KA; Denham A; Goodnight SH; Gandara DR
    Cancer Chemother Pharmacol; 1989; 23(5):316-8. PubMed ID: 2706738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of doxorubicin and epirubicin in mice during chlorpromazine-induced hypothermia.
    Lundgren-Eriksson L; Carlsson A; Eksborg S; Ryd W; Vesanen R; Hultborn R
    Cancer Chemother Pharmacol; 1997; 40(5):419-24. PubMed ID: 9272119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in accumulation of anthracyclines daunorubicin, doxorubicin and epirubicin in rat tissues revealed by immunocytochemistry.
    Shin M; Matsunaga H; Fujiwara K
    Histochem Cell Biol; 2010 Jun; 133(6):677-82. PubMed ID: 20424853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effectiveness of Dexrazoxane for Extravasation of Anthracycline Antitumor Antibiotics - Reporting Measures Developed against Extravasation in the Hospital].
    Kawamoto S; Shirahata T; Katori T; Izumo T; Kadono H; Fujita H; Okamoto R
    Gan To Kagaku Ryoho; 2016 Dec; 43(13):2517-2521. PubMed ID: 28028257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.